Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin's effect on perfusion and hypoxia in human non-small cell lung cancer
2010-023120-24Phase 2Terminated
- Sponsor
- Maastro Clinic
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nitroglycerin in non-small cell lung cancer (NSCLC), sponsored by Maastro Clinic. Primary endpoint: Change in tumor perfusion. Started Oct 2011; status: terminated.
02
Drugs
nitroglycerin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2010-023120-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023120-24.